# Bio-Rad Shares Drop 5.2% in Sector Selloff

> Bio-Rad Laboratories falls 5.2% as medical device stocks tumble in sector-wide selling.
- Title: Bio-Rad Shares Drop 5.2% in Sector Selloff | Shortify
- Summary: Bio-Rad Laboratories falls 5.2% as medical device stocks tumble in sector-wide selling. Bio-Rad Laboratories shares dropped 5.2% on Thursday amid sector-wide…
- Keywords: bio-rad laboratories, medical devices, life sciences, sector selloff, repligen corporation, bruker corporation, adaptive biotechnologies, Bio-Rad, Shares, Drop, Sector, Selloff
- Source: Alphastreet - Earnings Decoded. Market Intelligence Delivered — https://news.alphastreet.com/bio-rad-laboratories-drops-5-2-amid-sector-wide-selling
- Author: AlphaStreet Newsdesk
- Published: 2026-10-01T17:32:55+00:00
- Read time: 1 min
- Topics: bio-rad laboratories, medical devices, life sciences, sector selloff, repligen corporation, bruker corporation, adaptive biotechnologies
## Bio-Rad Shares Drop
Bio-Rad Laboratories tumbled 5.2% on Thursday as a sector-wide selloff dragged down medical device and life sciences stocks across the board.
## Shares Closed at $357.93
Shares closed at $357.93, with the California-based company caught in a broader downdraft that sent several sector peers sharply lower on October 1, 2026.
## Sector Peers Fell Too
Repligen Corporation (RGEN) fell 6.4%, Bruker Corporation (BRKR) down 3.3%, and Adaptive Biotechnologies (ADPT) off 3.7%.
## Selloff Not Company-Specific
The decline wasn’t company-specific. Bio-Rad’s drop came alongside a wave of selling pressure that hit sector peers hard.
## Market Capitalization at $9.6bn
Volume reached 118,017 shares as the stock shed value throughout the session, bringing Bio-Rad’s market capitalization to $9.6 billion.
## What to Watch Next
Investors should monitor whether this sector weakness extends into Friday’s session or proves to be isolated repositioning.
## Key takeaway

Bio-Rad Laboratories shares dropped 5.2% on Thursday amid sector-wide selling pressure in medical devices and life sciences stocks.